Abstract
The development of antibiotic resistant organisms is especially concerning in lung transplantation. We recently broadened our perioperative prophylaxis to more aggressively prophylax for peri-operative pneumonia. We chose Piperacillin-Tazobactam (P-T) based on known nosocomial bacterial flora. We evaluated the impact of P-T based strategy on patient exposure to antibiotics, ICU length of stay (LOS), and incidence of resistant (R) organisms to P-T within 30 days post-op.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
